Detalhe da pesquisa
1.
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell
; 140(5): 652-65, 2010 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211135
2.
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common ß-chain cytokine receptor endocytosis.
Blood
; 139(5): 761-778, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780648
3.
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).
Int J Mol Sci
; 23(23)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36498916
4.
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
Cancer
; 127(7): 1068-1079, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616915
5.
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.
Acta Haematol
; 144(4): 458-464, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412552
6.
Energy metabolism and drug response in myeloid leukaemic stem cells.
Br J Haematol
; 186(4): 524-537, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31236939
7.
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.
Blood
; 129(23): 3074-3086, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28432220
8.
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.
Blood
; 125(11): 1772-81, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573989
9.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100311
10.
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
Blood
; 121(3): 489-98, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223358
11.
The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer.
Front Med (Lausanne)
; 10: 1209425, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502358
12.
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics.
Vaccines (Basel)
; 10(5)2022 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35632572
13.
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Clin Transl Med
; 12(12): e1146, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536477
14.
Advances in the treatment of chronic myeloid leukemia.
BMC Med
; 9: 99, 2011 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21867560
15.
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia.
Cancers (Basel)
; 13(20)2021 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680203
16.
Discordant PET Findings and a High Relapse Rate Characterize Hispanics With Hodgkin's Lymphoma Treated With ABVD.
Cancer Diagn Progn
; 1(3): 127-133, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35399309
17.
Blood cancer health disparities in the United States Hispanic population.
Cold Spring Harb Mol Case Stud
; 7(2)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593728
18.
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
Cells
; 10(11)2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831055
19.
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Cells
; 10(9)2021 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572038
20.
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
Oncogene
; 40(15): 2697-2710, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712704